✦ LIBER ✦

Hexamethylmelamine (NSC-13875) in the treatment of primary cancer of the lung with metastasis

✍ Scribed by Dr. Jaime G. de La Garza; David T. Carr; Dr. Harry F. Bisel

Publisher: John Wiley and Sons
Year: 1968
Tongue: English
Weight: 604 KB
Volume: 22
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(196809)22:3<571::aid-cncr2820220312>3.0.co;2-u

No coin nor oath required. For personal study only.

✦ Synopsis

Seventy patients with primary pulmonary cancer with metastasis received a micronized form of hexamethylmelamine (HXM) (NSC-13875) at dosages of 8 to 12 mg/kg/day given orally. Most patients had some nausea or vomiting

📜 SIMILAR VOLUMES

Hexamethylmelamine (NSC-13875) alone and

Hexamethylmelamine (NSC-13875) alone and in combination with 5-(3, 3-dimethyl-triazeno) imidazole-4-carboxamide (NSC-45388) in the treatment of advanced cancer

✍ David C. Stolinsky; Donald L. Bogdon; Joel Solomon; Joseph R. Bateman 📂 Article 📅 1972 🏛 John Wiley and Sons 🌐 English ⚖ 461 KB 👁 1 views

Discrimination of multiple primary lung

Discrimination of multiple primary lung cancers from intrapulmonary metastasis based on the expression of four cancer-related proteins

✍ Kenji Ono; Kenji Sugio; Hidetaka Uramoto; Tetsuro Baba; Yoshinobu Ichiki; Mitsuh 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 322 KB

The impact of zoledronic acid therapy in

The impact of zoledronic acid therapy in survival of lung cancer patients with bone metastasis

✍ Kostantinos Zarogoulidis; Eufimia Boutsikou; Pavlos Zarogoulidis; Ellada Elefthe 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 213 KB 👁 2 views

## Abstract Bone metastases occur in 20–40% of patients with lung cancer. Recent studies demonstrate a direct antiproliferative effect of 3rd generation bisphosphonates (BPs) on lung tumors, which may influence the survival. Therefore, we examined the clinical impact of zoledronic acid (ZOL; Zometa

The role of curative radiotherapy in the

The role of curative radiotherapy in the treatment of lung cancer

✍ Peter Coy; G. M. Kennelly 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 450 KB 👁 2 views

Cyclophosphamide (NSC 26271) versus the

Cyclophosphamide (NSC 26271) versus the combination of adriamycin (NSC 123127), 5-fluorouracil (NSC 19893), and cyclophosphamide in the treatment of metastatic prostatic cancer. A randomized trial

✍ Rowan T. Chlebowski; Robert Hestorff; Leonard Sardoff; John Weiner; Joseph R. Ba 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 460 KB 👁 1 views

Recent trends in the treatment of primar

Recent trends in the treatment of primary breast cancer

✍ Samuel Albert; Steven Belle; G. Marie Swanson 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 426 KB 👁 2 views